Skip to main content
. 2022 Jan 24;2022:9961412. doi: 10.1155/2022/9961412

Table 2.

Clinicopathological characteristics of breast cancer patients.

n (%)
Tumor size (mm) 8.2 ± 5.24
Histology
 IDC 40 (81.6)
 ILC 2 (4.1)
 Others 7 (14.3)
ER status
 + 30 (61.2)
 - 19 (38.8)
PR status
 + 28 (57.1)
 - 21 (42.9)
HER2 status
 + 35 (71.4)
 - 14 (28.6)

Abbreviations: ER: estrogen receptor; IDC: invasive ductal carcinoma; HER2: human epidermal growth factor receptor 2; ILC: invasive lobular carcinoma; PR: progesterone receptor.